CN210542778U - Novel tracheotomy sleeve hemostasis assembly - Google Patents
Novel tracheotomy sleeve hemostasis assembly Download PDFInfo
- Publication number
- CN210542778U CN210542778U CN201920766419.6U CN201920766419U CN210542778U CN 210542778 U CN210542778 U CN 210542778U CN 201920766419 U CN201920766419 U CN 201920766419U CN 210542778 U CN210542778 U CN 210542778U
- Authority
- CN
- China
- Prior art keywords
- hemostasis
- incision
- tube
- novel
- balloon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000023597 hemostasis Effects 0.000 title claims abstract description 65
- 238000002347 injection Methods 0.000 claims abstract description 30
- 239000007924 injection Substances 0.000 claims abstract description 30
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 26
- 210000003437 trachea Anatomy 0.000 claims abstract description 20
- 230000000740 bleeding effect Effects 0.000 abstract description 17
- 210000004877 mucosa Anatomy 0.000 abstract description 5
- 208000027418 Wounds and injury Diseases 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 description 19
- 208000034158 bleeding Diseases 0.000 description 16
- 238000002618 extracorporeal membrane oxygenation Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000006835 compression Effects 0.000 description 7
- 238000007906 compression Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
- 206010039509 Scab Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 229960002897 heparin Drugs 0.000 description 4
- 229920000669 heparin Polymers 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 230000004913 activation Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000010836 blood and blood product Substances 0.000 description 2
- 229940125691 blood product Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010062506 Heparin-induced thrombocytopenia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Landscapes
- Surgical Instruments (AREA)
Abstract
The utility model provides a novel trachea opens sleeve pipe hemostasis subassembly, including the outer tube and with outer tube fixed connection's stationary vane, the stationary vane divide into the outer tube and insert the intraductal long tube of trachea and expose with outside nozzle stub, the nozzle stub with the position that the stationary vane links to each other is equipped with the outer hemostasis gasbag of incision, the lateral wall and the first gas injection pipe intercommunication department of the outer hemostasis gasbag of incision are equipped with one-way gas injection valve. The position where the long tube is connected with the fixed wing is provided with an incision internal hemostatic air bag, and the communicated part of the side wall of the incision internal hemostatic air bag and the second air injection tube is provided with a one-way air injection valve. When in use, air can be respectively injected through the first and second air injection pipes to generate air bag pressure to press the bleeding part from the inside and the outside of the incision. The second gas injection pipe is connected with an air bag pressure gauge, and the pressure of the hemostasis air bag in the incision can be monitored according to the air bag pressure gauge so as to prevent tracheal mucosa injury.
Description
Technical Field
The utility model relates to a novel trachea opens sleeve pipe hemostasis subassembly, concretely relates to novel trachea opens sleeve pipe that is used for carrying out hemostasis to the incision after the trachea opens belongs to medical auxiliary instrument field.
Background
Extracorporeal membrane oxygenation (ECMO) is a very effective cardiopulmonary support means and plays an important role in the treatment of various severe respiratory and/or cardiac insufficiency. Patients in need of ECMO support are in a critically ill state, and their complications and severity are important factors affecting their prognosis. And the critical patient who supports mechanical ventilation for a long time by ECMO needs to carry out tracheotomy, the tracheotomy can improve the comfort of the patient and the safety of an artificial airway, the dosage of a sedative is reduced, the airway management is convenient, but blood scabs are not easily formed on the wound after invasive operation is carried out under the support of ECMO, so the bleeding at the incision after the operation is the most common complication of ECMO. The postoperative bleeding is mainly caused by the fact that blood is led out of the body during ECMO treatment and then needs to be in contact with a large number of non-physiological foreign body surfaces such as pipelines and oxygenators, and in order to prevent thrombosis, a systemic heparinization method is needed for anticoagulation treatment, so that ACT is kept at 200-220 s. Severe platelet consumption during ECMO, heparin-induced thrombocytopenia syndrome, and other factors all contribute to a dramatic decrease in platelets, leading to frequent bleeding in patients.
Bleeding of different degrees appears in ECMO postoperative tracheotomy wounds reported in the prior literature, particularly bleeding is more in 24 hours, and the bleeding amount is 10-100 ml/d. The commonly used clinical treatment method for the tracheostomy bleeding at this time comprises the following steps: monitoring the coagulation function of a patient, in particular the platelet count, to maintain it at 5X 109Above this level, platelets need to be infused; considering reducing the heparin dosage, monitoring 1 ACT every 2-6 h, and adjusting the heparin dosage according to the ACT so as to control the ACT within 140-160 s within 24h of autogenous cutting, wherein if the bleeding amount is more than 100mL/d, the heparin usage is considered to be suspended; and the hemostatic medicine Yunnan white drug powder or thrombin is applied topically for wet compress; giving manual pressing operation incision or surgical suture again when the amount of bleeding is large; continuously applying sedative within 48h after the operation so as to reduce the traction to the wound when the patient is agitated; the sputum aspiration is gentle and gentle, and the sputum aspiration times can be reduced within 24h after the operation. The above treatments are mainly monitoring treatments aiming at the whole body blood coagulation function, the required monitoring means and the supporting treatment steps are various, the cost is high, and the great influence is caused to the family of patientsThe financial pressure of (a). The method has few high-efficiency methods for treating the local hemorrhage after tracheotomy, the local hemorrhage after tracheotomy is mainly the local capillary blood seepage at the incision, the currently given local hemostatic drug wet dressing can not quickly promote the formation of blood scab and is easy to cause concurrent infection; when the amount of bleeding is large, manual pressing operation is generally carried out, so that the workload of medical staff is greatly increased; such as re-surgical suturing, can also add multiple pains to the patient.
Disclosure of Invention
For remedying the deficiency that exists in the field, the utility model provides a novel trachea opens sleeve pipe hemostasis subassembly cuts the position that sheathed tube outer tube and stationary vane are connected at ordinary trachea and sets up hemostasis gasbag, can inject air into through the gas injection pipe during the use and make it produce gasbag pressure oppression operation incision bleeding position. According to the anatomical characteristics of local tissues inside and outside the tracheotomy and the different pressures which can be born, the internal/external air bags of the tracheotomy are respectively arranged, so that the hemostasis can be better achieved, and the pressure of the air bags in the incision is monitored by using an air bag pressure meter, thereby preventing the tracheal mucosa from being damaged.
The utility model discloses a following technical scheme realizes:
the utility model provides a novel trachea opens sleeve pipe hemostasis subassembly, including the outer tube and with outer tube fixed connection's stationary vane, the stationary vane divide into the outer tube and insert the intraductal long tube of trachea and expose with outside nozzle stub, the nozzle stub with the position that the stationary vane links to each other is equipped with the outer hemostasis gasbag of incision, the lateral wall and the first gas injection pipe intercommunication department of the outer hemostasis gasbag of incision are equipped with one-way gas injection valve.
Preferably, the part of the long tube connected with the fixed wing is provided with an incision internal hemostatic air bag.
Preferably, the incision internal hemostasis balloon is injected with gas through a second gas injection pipe connected with a balloon pressure gauge.
Preferably, a one-way air injection valve is arranged at the joint of the hemostasis air bag in the incision and the second air injection pipe.
Preferably, the pressure of the hemostatic air bag in the incision is maintained between 25 and 30cmH20。
Preferably, the incision external hemostatic balloon and/or the incision internal hemostatic balloon is an annular balloon.
Preferably, the maximum outer diameter of the hemostatic balloon outside the incision is greater than the maximum outer diameter of the hemostatic balloon inside the incision.
Preferably, the novel tracheotomy sleeve hemostasis assembly of the utility model can also be used for compression hemostasis of tracheotomy incisions of other diseases.
Compared with the prior art, the utility model the advantage lies in:
1. the novel tracheotomy sleeve pipe hemostasis assembly utilizes the pressure of the hemostasis air bag to perform hemostasis by compression, increases a method for local high-efficiency hemostasis of a tracheotomy, replaces manual pressing, lightens the workload of medical workers, and reduces the probability of secondary surgical suture;
2. a novel trachea opens its hemostasis gasbag of sleeve pipe hemostasis subassembly and the junction department of gas injection pipe and be equipped with check valve, only need connect the syringe on the gas injection pipe and can pour into the air into and make it inflation, simple structure, the pressure of hemostasis by compression acts on the local point of bleeding reliably.
3. The novel tracheotomy sleeve pipe hemostasis assembly of the utility model can promote the formation of blood scabs by using the internal and external hemostasis air bags of the incision to compress the incision hemostasis in the internal and external parts of the fixed wings, reduce the activation of local bleeding on the whole body blood coagulation system during ECMO and reduce the use of blood products; the local wet dressing medication is reduced, and the method is safer and more reliable.
4. A novel trachea opens sleeve pipe hemostasis subassembly adjust and control the outer hemostasis gasbag pressure of incision according to local hemorrhage volume in a flexible way outside the incision.
5. A novel trachea opens sleeve pipe hemostasis subassembly pass through gasbag manometer monitoring incision internal hemostasis gasbag pressure for hemostasis gasbag pressure maintains 25-30cmH in the incision20, the tracheal mucosa can be protected from being damaged on the basis of compression hemostasis by cooperating with the external incision hemostasis air bag;
6. a novel trachea opens sleeve pipe hemostasis subassembly, can effectually avoid performing the operation 24h internal trachea incision bleed in a large number for the phenomenon of local oozing blood can not appear even to the amount of bleeding can be controlled. The use of whole-body heparin due to bleeding is avoided, the use amount of sedative can be reduced, a patient can be awake early, the sputum drainage is facilitated, and the occurrence of pneumonia related to a breathing machine is avoided. The benefits of the tracheotomy on the patient are fully exerted.
7. A novel trachea opens sleeve pipe hemostasis subassembly low in production cost cheap, can effectually save medical cost.
Drawings
Fig. 1 is a schematic structural view of an embodiment of a novel tracheotomy cannula hemostasis assembly of the invention.
The various reference numbers in the figures are listed below:
1-an outer tube; 11-short pipe; 12-a long tube;
2, a fixed wing; 21-connecting the binding band with the through hole;
3-hemostatic air bag outside incision; 31 — a first gas injection tube;
4-hemostatic air bag in incision; 41-second gas injection tube.
Detailed Description
In order to facilitate understanding of the present invention, the present invention will be described in more detail with reference to the accompanying drawings and specific embodiments.
As shown in fig. 1, a novel tracheotomy cannula hemostasis assembly comprises an outer tube 1 and a fixing wing 2 fixedly connected with the outer tube 1, wherein the fixing wing 2 divides the outer tube 1 into a long tube 12 inserted into an trachea and a short tube 11 exposed outside, and the long tube 12 is bent; the left end and the right end of the fixed wing 2 are provided with binding belt connecting through holes for fixing or penetrating through the sleeve binding belt. The position of the short pipe 11 connected with the fixed wing 2 is provided with an external incision hemostatic air bag 3, and the communication position of the side wall of the external incision hemostatic air bag 3 and the first air injection pipe 31 is provided with a one-way air injection valve. The novel tracheotomy sleeve hemostasis assembly utilizes the pressure generated when the external incision hemostasis air bag 3 arranged at the connecting part of the fixed wing 2 and the short pipe 11 injects air to perform compression hemostasis on the incision, increases a method for local high-efficiency hemostasis of the tracheotomy, is beneficial to fixing the novel tracheotomy sleeve, replaces manual pressing, reduces the workload of medical workers, and reduces the probability of secondary surgical suture; the composition can promote the formation of blood crust, relieve the activation of the whole body blood coagulation system and reduce the use of blood products; the local wet dressing medication is reduced, and the method is safer and more reliable; simple structure, its incision external hemostasis gasbag 3 is equipped with check valve with first gas injection pipe 31 junction, only needs to connect the syringe on first gas injection pipe 31 and can inject into the air and make it expand for the reliable effect of pressure of hemostasis by compression is at the point of bleeding, low in production cost, the effectual medical cost that saves.
A novel trachea opens its first gas injection pipe 31 of sleeve pipe hemostasis subassembly and can regulate and control the pressure value of incision external hemostasis gasbag 3 according to bleeding volume in a flexible way.
Preferably, the long tube 12 is provided with an incision hemostatic air bag at the connection part with the fixed wing 2. Further increasing the reliability of incision hemostasis and protecting the tracheal mucosa to a certain extent.
Preferably, the incision internal hemostasis balloon 4 is inflated through a second inflation tube 41 connected with a balloon manometer. Preferably, a one-way air injection valve is arranged at the joint of the hemostasis air bag in the incision and the second air injection pipe.
The air bag pressure gauge adopts a German special air bag pressure gauge which has the functions of air injection, air discharge and pressure measurement, and preferably, the pressure of the hemostatic air bag in the incision is maintained at 25-30cmH2O; and the correction is carried out once every 4h, so that the hemostatic air bag in the incision can accurately reach the specified pressure value, and the tracheal mucosa is protected to prevent the ischemic injury of the trachea.
Preferably, the incision external hemostatic balloon and/or the incision internal hemostatic balloon is an annular balloon. The external hemostatic air bag outside the incision and/or the external ring of the annular air bag inside the incision can be respectively communicated with the air injection pipes at different parts of the fixed wing 2, and the air injection pipes can be connected with an air bag pressure measuring meter.
Preferably, the maximum outer diameter of the hemostatic balloon outside the incision is larger than the maximum outer diameter of the hemostatic balloon inside the incision, so as to obtain better hemostatic effect.
Preferably, the novel tracheotomy sleeve hemostasis assembly of the utility model can also be used for compression hemostasis of tracheotomy incisions of other diseases.
It should be noted that the above-described embodiments may enable those skilled in the art to more fully understand the present invention, but do not limit the present invention in any way. Therefore, although the present invention has been described in detail with reference to the drawings and examples, it will be understood by those skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope of the invention.
Claims (8)
1. The utility model provides a novel trachea opens sleeve pipe hemostasis subassembly, including the outer tube and with outer tube fixed connection's stationary vane, the stationary vane divide into the outer tube and is used for inserting the intraductal long tube of trachea and exposes in outside nozzle stub, its characterized in that, the nozzle stub with the position that the stationary vane links to each other is equipped with the outer hemostasis gasbag of incision, the lateral wall and the first gas injection pipe intercommunication of the outer hemostasis gasbag of incision just communicate the department and be equipped with one-way gas injection valve.
2. The novel tracheotomy cannula hemostasis assembly of claim 1, wherein an incision hemostasis balloon is provided at the location where the elongated tube is connected to the fixation wing.
3. The novel tracheostomy tube hemostasis assembly of claim 2 in which the intraoral hemostasis balloon is inflated through a second inflation tube to which is attached a balloon manometer.
4. The novel tracheotomy cannula hemostasis assembly of claim 3, wherein a one-way gas injection valve is arranged at the joint of the hemostasis balloon in the incision and the second gas injection tube.
5. The novel tracheotomy cannula hemostasis assembly of claim 4, wherein the intra-incision hemostasis balloon pressure is maintained at 25-30cmH2O。
6. The novel tracheotomy cannula hemostasis assembly of claim 3 or 4, wherein the intra-incision hemostasis balloon pressure is maintained at 25-30cmH2O。
7. The novel tracheostomy tube hemostatic assembly of claim 2, wherein the outer and/or inner hemostatic balloons are annular balloons.
8. The novel tracheostomy tube hemostatic assembly of claim 7, wherein the maximum outer diameter of the outer hemostatic balloon is greater than the maximum outer diameter of the inner hemostatic balloon.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920766419.6U CN210542778U (en) | 2019-05-24 | 2019-05-24 | Novel tracheotomy sleeve hemostasis assembly |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201920766419.6U CN210542778U (en) | 2019-05-24 | 2019-05-24 | Novel tracheotomy sleeve hemostasis assembly |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN210542778U true CN210542778U (en) | 2020-05-19 |
Family
ID=70666238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201920766419.6U Expired - Fee Related CN210542778U (en) | 2019-05-24 | 2019-05-24 | Novel tracheotomy sleeve hemostasis assembly |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN210542778U (en) |
-
2019
- 2019-05-24 CN CN201920766419.6U patent/CN210542778U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4753236A (en) | Temporary anastomotic device | |
| CN210542778U (en) | Novel tracheotomy sleeve hemostasis assembly | |
| CN204181677U (en) | Disposable pair of capsule ventilation nasal cavity hemostatic catheter | |
| CN207136883U (en) | A kind of Nephrology dept.'s tourniquet | |
| CN103720501A (en) | Nasal cavity hemostat, sinus cavity hemostat and hemostasis operation method | |
| Woldorf et al. | Extreme epinephrine sensitivity with a general anesthesia | |
| CN201533855U (en) | Rapid hemostasis dressing for nasal cavity | |
| CN203089259U (en) | Nasal cavity rapid hemostatic airbag | |
| CN207562209U (en) | Percutaneous renal puncture double-jacket tube | |
| CN204147164U (en) | A kind of internal arteriovenous fistula physiotherapy belt | |
| CN113069191A (en) | Puncture cannula for tension pneumothorax clinical first aid | |
| CN203424969U (en) | Convenient-to-tighten anal fistula seton | |
| CN207591068U (en) | Double anti-double capsule tracheostomy cannulas | |
| CN207055585U (en) | A kind of double-deck Orthopeadic Surgery pressurization strap device | |
| CN209932880U (en) | Adjustable blood vessel ring contraction band | |
| CN208389163U (en) | Multi-cavity catheter | |
| CN209269827U (en) | Bronchoscope imports casing | |
| CN208551907U (en) | Operation on uterus uterine hemostasis device | |
| CN111714744A (en) | Non-inflatable cuff and endotracheal intubation | |
| RU2411920C1 (en) | Nasal cannula-protector for newborn babies | |
| CN212066793U (en) | Appearance is aerifyd to accurate accuse pressure volume of gasbag | |
| CN208640799U (en) | A kind of percutaneous tracheal tube of hemostasis by compression | |
| CN203693675U (en) | Double-cavity nasal catheter hemostat | |
| CN220002650U (en) | Double-air-bag trachea cannula | |
| CN213609124U (en) | Novel pneumatic device for automatically correcting pressure of air bag |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200519 |